Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?

F. Bodur Yildirim (Ankara, Turkey), N. Sevimli (Ankara, Turkey), M. TüRk (Kayseri, Turkey), N. YiLmaz Demirci (Ankara, Turkey), A. Yurdakul (Ankara, Turkey), C. öZtüRk (Ankara, Turkey)

Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Session: Lung cancer: novel prognostic markers and scores
Session type: Thematic Poster
Number: 2785
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Bodur Yildirim (Ankara, Turkey), N. Sevimli (Ankara, Turkey), M. TüRk (Kayseri, Turkey), N. YiLmaz Demirci (Ankara, Turkey), A. Yurdakul (Ankara, Turkey), C. öZtüRk (Ankara, Turkey). Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?. 2785

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: